Abstract:Abstract Background: Esophageal cancer (EC) is a malignant tumor with dreadful mortality, nomogram is a prognosis tool of great significance in therapeutic guidance and assessment. We aimed to establish a newly-built nomogram for OS prediction of EC patients with radical esophagectomy.Methods: A total of 311 EC patients underwent radical esophagectomy were retrospectively investigated with their survival and demographic and clinicopathological data. Patients were randomly divided into the primary and validation cohorts. The establishment of nomogram was based on Cox hazard regression analysis in primary cohort, the calibration curves and Harrell’s concordance index were performed to verify the predictive accuracy while ROC curves was adopted to reflect the efficacy of nomogram. Kaplan–Meier curves showed the clinical significance of risk classification system and Pearson correlation test was utilized to show the correlation between risk classification system and TNM staging.Results: The median OS and 5-year survival rate are 44 months and 29.8% in primary cohort. In validation cohort, they are 52 months and 27.1%, respectively. In Cox hazard regression analysis, we extracted six independent prognostic factors—age, gender, AGR, PRL, N stage, PNI—to establish the nomogram. The C-index of nomogram is 0.75 in primary cohort and 0.70 in validation cohort. Calibration curves indicated high consistency between accurate and predicted OS in both primary and validation cohorts. ROC curves showed a better efficacy of nomogram compared with AJCC T and N stage. The area under curve (AUC) of primary cohort is 0.801 and 0.727 in validation cohort. Patients in primary cohort were divided into three risk groups according to the nomogram score, the median OS between each group was significantly different. Analogical results were obtained in validation cohort. Furthermore, the risk classification system was strongly correlated to AJCC TNM staging system in total cohort (r2=0.647, P<0.001), and it also demonstrated a better OS prediction efficacy (AUC=0.742).Conclusions: We established a neotype nomogram and a relevant risk classification system with verified accuracy and efficacy in OS prediction of EC patients after radical esophagectomy. They may provide feasible value in prognosis assessment and treatment guidance prospectively.

Prognostic nomogram in patients with right-sided colon cancer after colectomy: a surveillance, epidemiology, and end results–based study

Development and Validation of the Individualized Prognostic Nomograms in Patients With Right- and Left-Sided Colon Cancer

A Nomogram Predicting the Prognosis of Renal Cell Carcinoma Patients with Lung Metastases

Establishment and Validation of a Prognostic Nomogram for Patients with Renal Cell Carcinoma Based on SEER and TCGA Database

Prognostic Nomogram for Patients with Radical Surgery for Non-Metastatic Colorectal Cancer Incorporating Hematological Biomarkers and Clinical Characteristics

Prognostic Nomograms for Patients with Metastatic Gastric Cancer: A Large Population-Based Cohort Study and External Validation

A neotype nomogram based on accessible clinical indicators to predict the overall survival of esophageal cancer patients underwent radical resection

Prognostic Nomogram for Colorectal Cancer Patients with Multi-Organ Metastases: a Surveillance, Epidemiology, and End Results Program Database Analysis.

Establishment and Validation of a Prognostic Nomogram for Predicting Postoperative Overall Survival in Advanced Stage III–IV Colorectal Cancer Patients

An internally and externally validated nomogram for predicting cancer-specific survival in octogenarians after radical resection for colorectal cancer

Nomograms for Predicting Specific Distant Metastatic Sites and Overall Survival of Colorectal Cancer Patients: A Large Population-Based Real-World Study.

Construction of a prognostic nomogram for predicting the postoperative metastasis risk of patients with non-metastatic color-ectal cancer

Development and Validation of Nomograms for Predicting Survival in Patients with Non-Metastatic Colorectal Cancer

Development and Validation of a Nomogram to Predict Overall Survival in Stage I–III Colorectal Cancer Patients after Radical Resection with Normal Preoperative Serum Carcinoembryonic Antigen

Development and Validation of a Prognostic Scoring System for Patients with Colorectal Cancer Hepato-Pulmonary Metastasis: a Retrospective Study

Construction and Validation of a Simple-to-use Nomogram Incorporating Clinicopathological Parameters into the TNM Staging System to Predict Prognosis for Stage II Colorectal Cancer

Personalizing Prognostic Prediction In Early-Onset Colorectal Cancer

Construction and validation of a nomogram for predicting overall survival of patients with stage III/IV early−onset colorectal cancer

A Nomogram and Risk Classification System Forecasting the Cancer-Specific Survival of Lymph- Node- Positive Rectal Cancer Patient after Radical Proctectomy

Prognostic Nomograms for Predicting Cause-Specific Survival and Overall Survival of Stage I–III Colon Cancer Patients: a Large Population-Based Study

Development and validation of a prognostic nomogram for early stage non-small cell lung cancer: a study based on the SEER database and a Chinese cohort